https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4755-815d-99adf40ddc17
There have been a number of scenarios of Real World Evidence (RWE) that IMO support Mesoblast's decision to plan to run and additional COVID-19 ARDS Phase 3 trial using Remestemcel-L ... I thought we could use this thread to post them as we come across them ? Use the thread or don't use it; entirely up to you
An exponential increase in case numbers like this - 1,044,970 new cases in one day and USA hospitalisations up by 41% in two weeks would IMO support SI's reasons for undertaking an additional COVID-19 ARDS Phase 3 trial in the USA using our Remestemcel-L treatment.
https://www.nbcnews.com/news/us-new...-covid-cases-spread-omicron-variant-rcna10866
U.S. reaches 1 million daily Covid cases in spread of omicron variant
https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.035(3.03%) |
Mkt cap ! $1.353B | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.20 | $1.16 | $7.533M | 6.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 70825 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 82177 | 6 |
View Market Depth
| Last trade - 12.51pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.21 |
Change
0.035 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.21 | $1.16 | 565460 | ||
| Last updated 13.13pm 28/05/2024 ? | |||||
| MSB (ASX) Chart |